Generics 17

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Nimodipine manufacturers

17 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

17 products found

nimodipine

Vials, injection 10 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #2303

Manufacturer usually replies in 23 days

nimodipine

Tablets 30 mg

Dossier type
ACTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530
This pharmaceutical company specializes in a diverse range of products including prescription medications, over-the-counter drugs, medical devices, and supplements. They hold WHO-GMP certifications since 1965 and an ISO 9001:2015 certification, demonstrating their commitment to quality. Their expertise spans various therapy areas such as oncology/hormone therapies, cardiovascular health, and gastrointestinal conditions. They offer a wide range of dosage forms including capsules, tablets, syrups, and rectal suspensions. This company has a global presence, with products distributed across over 2000 countries. They are known for their contract manufacturing capabilities and new drug development expertise, holding over 300 ACTD dossiers.

Manufacturer usually replies in 13 days

nimodipine

Injection 10 mg/50 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.

Manufacturer usually replies in 20 days

Want to see all 17 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Nimodipine is a medication used to prevent migraines and treat ischemic stroke, and subarachnoid hemorrhage. Manufacturers of nimodipine produce it both as a standalone medication, in combination with citicoline. Nimodipine suppliers market it in the form of oral capsules, oral solutions, and intravenous liquids. The developer and earliest manufacturer of nimodipine is Bayer, who first introduced it into the pharmaceutical market in 1985 under the trade name Nimotop. Currently, the drug is approved in over 60 countries. Other major suppliers of nimodipine globally include Sun Pharmaceuticals, Heritage Pharmaceuticals, Bionpharma, Arbor, Thepharmanetwork, and Sofgen. Nimodipine suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified nimodipine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail price per 100 (30mg) capsules of trade name nimodipine is approximately 130,00 EUR, whereas the equivalent amount of generic nimodipine tablets costs around 50,00 EUR to 60,00 EUR. A single vial of trade name 10mg/50ml nimodipine injectable solution costs around 20,00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.